Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-25

FDA Approved: VIGABATRIN FOR ORAL SOLUTION — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' supplemental application to market Vigabatrin as an oral solution, expanding the available dosage form of this anticonv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin for oral solution (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN FOR ORAL SOLUTION (VIGABATRIN)